德适-B(02526)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02526 德适-B

休市中 07-03 16:08:13

310.000

+4.000

+1.31%

最高316.000	最低304.600	成交量5.11万
今开310.000	昨收306.000	日振幅3.73%
总市值275.53亿	流通市值275.53亿	总股本8,888万
成交额1,586万	换手率0.06%	流通股本8,888万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02526","market":"HK","secType":"STK","nameCN":"德适-B","latestPrice":310,"timestamp":1783066093374,"preClose":306,"halted":0,"volume":51090,"delay":0,"changeRate":0.013071895424836602,"floatShares":88879200,"shares":88879200,"eps":-0.9700361413610511,"marketStatus":"休市中","change":4,"latestTime":"07-03 16:08:13","open":310,"high":316,"low":304.6,"amount":15857402,"amplitude":0.037255,"askPrice":310,"askSize":100,"bidPrice":304,"bidSize":50,"shortable":0,"etf":0,"ttmEps":-0.9665399490096097,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":7,"adr":0,"listingDate":1774800000000,"exchange":"SEHK","adjPreClose":306,"openAndCloseTimeList":[[1783042200000,1783051200000],[1783054800000,1783065600000]],"volumeRatio":0.9552318082315616,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02526","defaultTab":"news","newsList":[{"id":"1113128326","title":"德适-B 6月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1113128326","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113128326?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:37","pubTimestamp":1782981436,"startTime":"0","endTime":"0","summary":"杭州德適生物科技股份有限公司（德适-B，股票代码：02526）于2026年7月2日发布截至2026年6月30日的证券变动月报表。公告显示，公司本月底注册股本维持在人民币88,879,200元，已发行普通股（H股）总数与上月底一致，均为88,879,200股，面值每股人民币1元。本月未发生新增发行、购回、注销或库藏股变动。\n报告显示，公司已符合香港联交所关于最低公眾持股量17.05%的要求，确认遵守《上市规则》及其他相关法律法规。公司表示目前不存在股份期权、权证、可换股票据及其他相关衍生工具的发行、交易或变动情况。\n该公告由公司执行董事宋宁签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647453054","title":"55家公司港股通新贵即将喜迎北水流入 入通门槛或已抬升至102.67亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647453054","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647453054?lang=zh_cn&edition=full","pubTime":"2026-07-01 10:09","pubTimestamp":1782871774,"startTime":"0","endTime":"0","summary":"核心规则：市值门槛动态调整截至2026年6月30日，港股通实际纳入门槛已升至102.67亿，剔除门槛达66.89亿。这一指标直接决定了个股在指数中的权重与港股通资格。对于不同上市时长的公司，要求有所不同：对于上市公司而言，维持日均万五左右的换手率是保住港股通资格的关键。数据截止日为每年的6月30日和12月31日，这也是上市公司\"冲关\"港股通的关键时间窗口。","market":"hk","thumbnail":"https://static.tigerbbs.com/0cf777090175126e4590c3b8afdfe41e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0cf777090175126e4590c3b8afdfe41e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461288.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01956","00376","02632","01672","03310","02729","03887","01609","07630","02726","01440","00412","02142","03388","02272","02616","01392","02526","06938","00600","01866","02672","07688","06106","09637","07666","02723","01236","03625","01651","01286","06658","02553","00068","02335","03355","06872","00340","00863","01021","02696","01133","06656","01081","06636","01879","09630","06675","03661","02670","01511","BK4585","01779","00100","01191","BK4588","03277"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2647328063","title":"格隆汇2026中期策略峰会“All in 硅基新纪元”暨“金格奖”——卓越公司榜单全部揭晓！","url":"https://stock-news.laohu8.com/highlight/detail?id=2647328063","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647328063?lang=zh_cn&edition=full","pubTime":"2026-06-29 13:08","pubTimestamp":1782709733,"startTime":"0","endTime":"0","summary":"本次评选共设有14个奖项","market":"hk","thumbnail":"https://img3.gelonghui.com/9dec8-575c2ec7-abca-4b10-b7d8-3bd3f2cd0682.jpg?guru_height=741&guru_width=1140&guru_size=148310","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/9dec8-575c2ec7-abca-4b10-b7d8-3bd3f2cd0682.jpg?guru_height=741&guru_width=1140&guru_size=148310"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5373783","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["09878","01024","06979","09678","03690","002714","07688","02553","000338","02526","02718","01951","300760","01021","002779","02643","02273","01952","02408","02555","02729","02511","002352","002594","01833","000951","03692","02661","001248","02121","02590","00600","00917","09959","000039","06668","02687","02170","02105","02279","002600","01519","01768","00780","01497","06963","09992","300364","01384","09880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120343235","title":"德适-B拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1120343235","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120343235?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:41","pubTimestamp":1780584074,"startTime":"0","endTime":"0","summary":"杭州德适生物科技股份有限公司宣布，将在2026年6月26日召开年度股东大会，审议向董事会授予一般性授权，用于回购最多相当于公司已发行H股股本10%的股份。于最后可行日期，公司已发行H股约88,879,200股。公司将于2026年6月23日至6月26日暂时关闭H股过户登记，以确定有权出席并表决的股东名单，股东需在2026年6月22日下午4时30分前完成H股过户并登记。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德适-B拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117105974","title":"德适-B公布2026年5月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1117105974","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117105974?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:37","pubTimestamp":1780562258,"startTime":"0","endTime":"0","summary":"杭州德适生物科技股份有限公司于2026年6月4日发布了截至2026年5月31日的证券变动月报表，披露了当月股本及相关变动情况。报告显示，截至2026年5月31日，公司注册股本为人民币88,879,200元，已发行普通股（H股）数量为88,879,200股，每股面值人民币1元。本次月报由公司执行董事宋宁签署。公司表示未来将继续严格遵守相关上市规则及法律法规，确保信息披露合规和股权结构稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638561575","title":"港股异动 | 德适-B(02526)涨超22%再创新高 核心产品AI AutoVision拿下医学影像基座大模型首张三类证","url":"https://stock-news.laohu8.com/highlight/detail?id=2638561575","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638561575?lang=zh_cn&edition=full","pubTime":"2026-05-26 09:43","pubTimestamp":1779759833,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德适-B早盘涨超22%，高见428港元，再创上市新高。消息面上，德适宣布，公司自研的AI AutoVision染色体核型辅助诊断软件正式获得国家药监局第三类医疗器械注册证。该证批准的适应症涵盖采用羊水样本进行出生缺陷产前诊断的染色体核型分析；及采用外周血样本进行辅助生殖相关染色体核型分析。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02526","AIPO","ARTY","BK1189","VXUS","BK4588","02251","CHAT","AGIX","BK1100","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131684681","title":"异动解读 | 首张大模型医械三类证落地，德适-B盘中大涨14.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131684681","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131684681?lang=zh_cn&edition=full","pubTime":"2026-05-26 09:38","pubTimestamp":1779759500,"startTime":"0","endTime":"0","summary":"德适-B今日盘中股价大幅拉升，涨幅达14.23%，市场关注度显著提升。消息面上，公司自研的AI AutoVision染色体核型辅助诊断软件正式获得国家药监局第三类医疗器械注册证，这是首张基于大模型技术获批的医疗器械注册证。公司2025年财报也显示其营收同比增长133.7%，技术许可收入首次成为第一大收入来源。这些积极进展共同增强了市场对公司未来增长潜力的信心，推动了股价的强势表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638561548","title":"德适(02526)盘初大幅走高15% 突破人工瓶颈 首张大模型医械三类证落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2638561548","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638561548?lang=zh_cn&edition=full","pubTime":"2026-05-26 09:36","pubTimestamp":1779759363,"startTime":"0","endTime":"0","summary":"金吾财讯 | 德适(02526)盘初大幅走高，现报402港元，涨14.86%，成交额1100万。消息面上，德适生物自研AI AutoVision染色体核型辅助诊断软件，成功获批国家药监局三类医疗器械注册证，成为全球首款依托大模型技术落地的医疗器械产品，创下辅助生殖与出生缺陷防控领域同类产品最快获批纪录。该产品依托德适生物iMedImage通用医学影像大模型打造，打破传统单病种模型局限，可适配超九成临床影像场景。临床数据显示，产品染色体数目异常检测双指标达100%，大幅缩短检测与出报告周期，自动化确率超99%，AI诊疗能力比肩资深专业人员。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1982132","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637311915","title":"全球首创类医学影像AI首获三类证：德适（02526）AI AutoVision®通过最高等级监管验证，技术护城河再加固","url":"https://stock-news.laohu8.com/highlight/detail?id=2637311915","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637311915?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:11","pubTimestamp":1779451903,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，5月22日，德适发布公告，公司自主研发的AI AutoVision染色体核型辅助诊断软件正式获得国家药监局第三类医疗器械注册证。这是出生缺陷防控、辅助生殖等领域获批速度最快的医学影像AI全球首创类产品，通过中国最高等级医疗器械注册验证。AI AutoVision的获批，直接打开了规模化入院通道，也为后续纳入医保支付体系奠定基础。AI AutoVision获批三类证后，规模化入院通道打开，核心产品催生的收入增长有望进一步加速。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AIPO","BK1100","CHAT","AGIX","ARTY","02251","BK1189","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637394428","title":"德适-B(02526)：AI AutoVision®获中国国家药品监督管理局第三类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2637394428","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637394428?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:32","pubTimestamp":1779438757,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德适-B 发布公告，于2026年5月20日，本公司核心产品AI AutoVision已获中国国家药品监督管理局颁发第三类医疗器械注册证。AI AutoVision是基于本集团iMedImage医学影像大模型打造的智能染色体核型分析产品，可辅助完成染色体分割、计数及排列，并提供异常识别提示辅助医师进行临床诊断。该注册证的取得是AI AutoVision的重要监管里程碑，为该核心产品在批准适应症范围内的商业化奠定基础。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","ARTY","CHAT","BK1100","AGIX","09996","BK1574","02526","159883","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636304327","title":"“2026智通财经夏季路演大会”活动报名中 ！","url":"https://stock-news.laohu8.com/highlight/detail?id=2636304327","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636304327?lang=zh_cn&edition=full","pubTime":"2026-05-18 10:06","pubTimestamp":1779069961,"startTime":"0","endTime":"0","summary":"5月28日，深圳前海。40+港股上市公司集中路演，与机构及高净值投资者面对面交流。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260518/20260518102433_43763.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260518/20260518102433_43763.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06682","HK0001040143.USD","00826","01333","00650","03881","01378","02142","06090","01021","02575","02228","02623","01907","02652","08299","06051","02670","00305","06636","02889","00363","06938","LU0287142896.SGD","01384","01300","03317","02685","02411","02655","BK1171","02565","03858","LU0314109678.HKD","00290","BK1155","01396","02729","02726","06651","VXUS","02659","LU0307460666.USD","02706","09696","02650","02675","BK1100","00400","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147563562","title":"异动解读 | 德适-B盘中大涨9.34%，2025年技术许可业务暴增331.7%引爆AI医疗商业闭环","url":"https://stock-news.laohu8.com/highlight/detail?id=1147563562","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147563562?lang=zh_cn&edition=full","pubTime":"2026-05-13 15:30","pubTimestamp":1778657445,"startTime":"0","endTime":"0","summary":"德适-B今日盘中大涨9.34%，引起了市场的广泛关注。消息面上，公司近日披露了2025年业绩报告，显示全年总收入达1.64亿元，同比激增133.7%；毛利1.18亿元，同比大增157%。尤为亮眼的是，技术许可业务收入从上年同期的1954万元飙升至8434万元，同比暴增331.7%，首次占据总营收的半壁江山，跃升为第一大收入来源。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635205747","title":"港股异动 | 德适-B(02526)尾盘涨超9% 全年技术许可暴增331.7% 医疗AI大模型商业闭环可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2635205747","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635205747?lang=zh_cn&edition=full","pubTime":"2026-05-13 15:23","pubTimestamp":1778657027,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德适-B尾盘涨超9%，截至发稿，涨%9.01，报326.8港元，成交额4048.94万港元。消息面上，德适近日披露2025年业绩。全年总收入1.64亿元，同比激增133.7%；毛利1.18亿元、同比大增157%。智通财经APP在《德适-B：技术许可暴增331.7%引爆“造血”元年，以基座模型构筑全球AI医疗基础设施》中指出，德适2025年的年报，无疑是其迄今最有力的一次自我证明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["150261","02526","VXUS","BK1100","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117488107","title":"德适-B2026年4月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1117488107","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117488107?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:36","pubTimestamp":1778142999,"startTime":"0","endTime":"0","summary":"杭州德適生物科技股份有限公司（股票代码：02526，股票名称：德适-B）于2026年5月7日发布2026年4月股份变动月报表，报告期为2026年4月1日至4月30日。公告显示，公司注册股本为人民币88,879,200元，至本期末无增减变化；普通股（H股）总数维持在88,879,200股，库藏股份数量为0，股本结构保持不变。\n报告期内，公司无新增发行、购回或注销股份，也无期权及股权激励计划相关变动。公司确认其在本期间持续满足香港联交所《上市规则》及相关法律法规要求。截至2026年4月30日，公司股本及已发行股份总数保持稳定。\n据悉，本次公告由公司执行董事宋宁签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633897050","title":"德适首份年报：全年收入约1.64亿元，同比增约133.7%，毛利率达71.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633897050","media":"广州日报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633897050?lang=zh_cn&edition=full","pubTime":"2026-05-06 11:56","pubTimestamp":1778039819,"startTime":"0","endTime":"0","summary":"“全球医学影像大模型第一股”——杭州德适生物科技股份有限公司（股票代码：2526.HK，以下简称“德适”）日前发布了上市后首份年度业绩报告：公司全年实现收入约1.64亿元，同比实现约133.7%的强劲增长；毛利约1.18亿元，毛利率显著提升至约71.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605063728452275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145540772","title":"异动解读 | 德适-B盘中大涨15.69%，创上市新高，广交会亮相及技术许可收入暴增提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1145540772","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145540772?lang=zh_cn&edition=full","pubTime":"2026-05-04 10:37","pubTimestamp":1777862241,"startTime":"0","endTime":"0","summary":"德适-B(02526)今日盘中大幅上涨15.69%，股价创下上市以来的历史新高，引起了市场的广泛关注。消息面上，公司近期携自主研发的iMedImage®医学影像基座大模型亮相第139届广交会智慧医疗专区，展台吸引了来自中东、东南亚及欧洲等地采购商的浓厚兴趣，市场对其技术实力和国际化前景给予了积极反馈。此外，根据公司2025年年报，其技术许可收入同比暴增332%，成功验证了其大模型商业闭环的可行性。同时，iMedImage®基座模型获得了腾讯等头部机构的战略背书，进一步巩固了其作为全球AI医疗基础设施服务商的行业地位与战略价值，多重利好共同推动了本次股价的强劲表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632982546","title":"港股异动 | 德适-B(02526)涨超15%创上市新高 德适携自研iMedImage®医学影像基座大模型亮相广交会","url":"https://stock-news.laohu8.com/highlight/detail?id=2632982546","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632982546?lang=zh_cn&edition=full","pubTime":"2026-05-04 10:27","pubTimestamp":1777861643,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德适-B早盘涨超15%，高见335港元创上市新高，较招股价99港元已涨近240%。德适携自主研发的iMedImage医学影像基座大模型亮相，展台前人流如织，来自中东、东南亚、欧洲等地的采购商对其技术和产品表现出浓厚兴趣。技术许可收入暴增332%，验证了大模型商业闭环的可行性；30.6%的市占率，守住了政策性刚需赛道的绝对领先地位；而iMedImage基座模型获得腾讯等头部机构的背书，则深刻印证了其作为全球AI医疗基础设施服务商的战略价值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437759.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","VXUS","02251","BK4585","IPOS","BK1100","BK4588","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146307854","title":"德适-B2025年AI影像业务高速扩张，收入同比增133.7%，研发投入大幅攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=1146307854","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146307854?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:36","pubTimestamp":1777473399,"startTime":"0","endTime":"0","summary":"2025年，杭州德适生物科技股份有限公司围绕其核心的数字化与智能化发展战略，在医学影像智能化等智慧医疗领域推进约5,000个项目与3,200余项研发任务，巩固了在AI影像诊断及多元化智慧医疗产品方面的竞争力。公司持续扩展技术许可收入来源，并通过iMedImage、AI AutoVision等医学影像及数字化解决方案，深化与医疗机构的科研与治疗合作，覆盖超声、X光、CT、MRI等多类应用场景及拓展领域。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德适-B2025年AI影像业务高速扩张，收入同比增133.7%，研发投入大幅攀升","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631988395","title":"德适-B(02526)建议采纳股份激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2631988395","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631988395?lang=zh_cn&edition=full","pubTime":"2026-04-29 16:49","pubTimestamp":1777452590,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德适-B(02526)发布公告，董事会已于2026年4月29日举行的董事会会议上决议建议采纳股份激励计划，以促进其长期可持续发展，吸引及留住对集团长期增长及成功作出贡献的合资格参与者，使激励对象、股东及公司的利益保持一致，并优化公司的激励结构。受限制股份单位及购股权的授予应透过以下方式拨付：受托人将于二级市场购买的H股;公司将予发行的新H股;及公司合法持有的库存股份(如有)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301122","BK1100","BK0251","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629049899","title":"德适：iMedImage医学影像基座模型覆盖超90%临床医学影像场景，可将专病AI模型研发成本降低90%以上","url":"https://stock-news.laohu8.com/highlight/detail?id=2629049899","media":"新浪科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629049899?lang=zh_cn&edition=full","pubTime":"2026-04-22 20:27","pubTimestamp":1776860820,"startTime":"0","endTime":"0","summary":"新浪科技讯 4月22日晚间消息，在2026第十届万物生长大会上，杭州德适生物科技股份有限公司携自研iMedImage医学影像基座模型，亮相“杭州AI十八罗汉”联展区。　　本次参展，德适重点展出两大核心产品：自主研发的iMedImage医学影像基座模型，以及基于该模型打造的AI AutoVision 染色体核型辅助诊断软件。据现场负责人介绍，iMedImage支持染色体、CT、MRI、超声及病理等19种医学影像模态，覆盖超90%的临床医学影像场景。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/2026-04-22/doc-inhvkqfy9348178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ARTY","CHAT","BK1189","AGIX","AIPO","02251","BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.diagens.com","stockEarnings":[{"period":"1week","weight":0.0368},{"period":"1month","weight":-0.0549},{"period":"3month","weight":0.3248},{"period":"6month","weight":2.1313},{"period":"ytd","weight":2.1313}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":-0.0891},{"period":"3month","weight":-0.0703},{"period":"6month","weight":-0.1135},{"period":"1year","weight":-0.0299},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州德适生物科技股份有限公司(简称“德适生物”),是全球医学影像AI与医疗影像装备领域的领先企业,业务覆盖全球市场。依托自主研发的通用医学影像基座模型iMedImage,公司成功打造出多元化的智能装备及配套产品矩阵,包括AutoVision染色体核型分析系统、MetaSight自动细胞显微图像扫描系统、KayoFlow自动细胞收获仪与制片染色一体机等,可满足临床多场景需求。公司客户已覆盖全国400多家医疗保健中心与医疗机构,获得市场广泛认可。未来,公司将持续为全球客户提供标准化智能成像设备、模型即服务(MaaS)云平台及本地化自训练解决方案,以技术创新提升医学影像诊断的效率、准确率与可及性,引领全球医学影像行业进入智能化时代。","exchange":"SEHK","name":"德适-B","nameEN":"DIAGENS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德适-B(02526)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德适-B(02526)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德适-B,02526,德适-B股票,德适-B股票老虎,德适-B股票老虎国际,德适-B行情,德适-B股票行情,德适-B股价,德适-B股市,德适-B股票价格,德适-B股票交易,德适-B股票购买,德适-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德适-B(02526)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德适-B(02526)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}